ALVOW
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$0.26
−42.17%Forward multiples
Based on analyst estimates
- P/E forward
- 1.11x
- P/E 2026E
- —
- P/E 2027E
- 1.14x
- P/E 2028E
- 0.59x
- P/S forward
- 0.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.41x
- Price / sales
- 0.16x
- Price / cash flow
- -0.39x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 2.82x
- EV / EBITDA
- 212.32x
- EV / EBIT
- 29.31x
- Market cap
- $78.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026